(Q50765634)

18 March 2018

title

Chronic red blood cell exchange to prevent clinical complications in sickle cell disease. (English)

1 reference

18 March 2018

0 references

Sergio Cabibbo

1

1 reference

18 March 2018

Carmelo Fidone

2

1 reference

18 March 2018

Giovanni Garozzo

3

1 reference

18 March 2018

Agostino Antolino

4

1 reference

18 March 2018

Giovanna Oriella Manenti

5

1 reference

18 March 2018

Francesco Bennardello

6

1 reference

18 March 2018

Vincenzo Licitra

7

1 reference

18 March 2018

Salvatore Calabrese

8

1 reference

18 March 2018

Francesco Costantino

9

1 reference

18 March 2018

Simone Travali

10

1 reference

18 March 2018

Roberto Distefano

11

1 reference

18 March 2018

Pietro Bonomo

12

1 reference

18 March 2018

publication date

1 June 2005

1 reference

18 March 2018

Transfusion and Apheresis Science

published in

1 reference

18 March 2018

volume

32

1 reference

18 March 2018

issue

3

1 reference

18 March 2018

page(s)

315-321

1 reference

18 March 2018

The role of red blood cell exchange transfusion in the treatment and prevention of complications of sickle cell disease.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.03.003

Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.03.003

Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.03.003

Erythrocyte autoantibodies in paediatric patients with sickle cell disease receiving transfusion therapy: frequency, characteristics and significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.03.003

Current issues with blood transfusions in sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.03.003

Erythrocytapheresis for chronically transfused children with sickle cell disease: an effective method for maintaining a low hemoglobin S level and reducing iron overload

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.03.003

In vivo and in vitro characteristics of double units of RBCs collected by apheresis with a single in-line WBC-reduction filter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.03.003

Long-term red blood cell exchange can be used to successfully treat sickle cell intrahepatic cholestasis: a case report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.03.003

Therapeutic challenges in childhood sickle cell disease. Part 1: current and future treatment options

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.03.003

Hyperhemolytic transfusion reaction in sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.03.003

[Transfusion and alloimmunization in sickle cell anemia patients]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.03.003

Two-unit red cell apheresis and its potential advantages over traditional whole-blood donation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.03.003

Extended storage of AS-1 and AS-3 leukoreduced red blood cells for 15 days after deglycerolization and resuspension in AS-3 using an automated closed system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.03.003

In vivo survival of apheresis RBCs, frozen with 40-percent (wt/vol) glycerol, deglycerolized in the ACP 215, and stored at 4 degrees C in AS-3 for up to 21 days

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.03.003

10.1016/J.TRANSCI.2005.03.003

7 January 2021

Identifiers

DOI

1 reference

18 March 2018

1 reference

18 March 2018